2005

Bradley LA, Palomaki GE, McDowell GA, Down Syndrome Working Group, ACMG Laboratory Quality Assurance Committee:  Technical standards and guidelines: prenatal screening for open neural tube defects.  Genet Med, 7:355-369, 2005.

Boyle CA, Ladenson P, Haddow JE:  Methods and criteria used in evidence-based decisions in public health.  Thyroid, 15:41-43, 2005.

Haddow JE:  Couple screening to avoid thalassemia: successful in Iran and instructive for us all.  J Med Screen, 12:55-56, 2005.

Haddow JE: Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol, 106:198, 2005.

Hollowell JG, LaFranchi S, Smallridge RC, Spong CY, Haddow JE, Boyle CA:  2004 Where do we go from here?  Summary of working group discussions on thyroid function and gestational outcomes.  Thyroid, 15:72-76, 2005.

Isman F, Palomaki GE, Natowicz MR: Lysosomal enzymes in human peripheral blood mononuclear cells and granulocytes.  Clin Chem, 51:646-649, 2005.

Knight GJ, Palomaki GE, Klee GG, Schreiber WE, Cole LA:  A comparison of human chorionic gonadotropin-related components in fresh frozen serum with the proficiency testing material used by the College of American Pathologists.  Arch Pathol Lab Med, 129:328-330, 2005.

Knight GJ, Palomaki GE, Neveux L, Smith DE, Kloza EM, Pulkkinen AJ, Williams J, Haddow JE: Integrated serum screening for Down's syndrome in primary obstetric practice. Prenat Diagn , 22:1162-1167, 2005.

LaFranchi S, Haddow JE, Hollowell JG:  Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?  Thyroid, 15:60-71, 2005.

Law MR, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C, Reid T, Schrag S: The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society.  J Med Screen, 12:60-68, 2005.

McClain MR, Palomaki GE, Nathanson KL, Haddow JE: Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.  Genet Med, 71:28-33, 2005.

McClain MR, Nathanson KL, Palomaki GE, Haddow JE: An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.  Genet Med, 7:34-39, 2005.

Palomaki GE, Bradley LA, McDowell GA, Down Syndrome Working Group, ACMG Laboratory Quality Assurance Committee:  Technical standards and guidelines: prenatal screening for Down syndrome.  Genet Med, 7:344-354, 2005.

Palomaki GE, Knight GJ, Neveux LM, Pandian MR, Haddow JE: Maternal serum invasive trophoblast antigen and first trimester Down syndrome screening.  Clin Chem, 51:1499-1504, 2005.

Palomaki GE, Kloza EM, Haddow JE, Williams J, Knight GJ: Patient and health professional acceptance of integrated serum screening for Down syndrome. Semin Perinatol, 29:247-251, 2005.

Palomaki GE, McClain MR, Haddow JE: ACCE reviews of genetic tests: BRCA1, BRCA2, and CFTR. In: Genomics and Population Health: United States 2005. Centers for Disease Control and Prevention, Office of Genomics and Disease Prevention. Atlanta, Georgia, 2005, pp. 27-33. Also available at http://www.cdc.gov/genomics/activities/ogdp/2005.htm.

Schreiber WE, Endres DB, McDowell GA, Palomaki GE, Elin JR, Klee GG, Wang E:  Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists Surveys: alpha-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin and prostate-specific antigen.  Arch Pathol Lab Med, 129:331-337, 2005.

Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ, Bradley LA, Prior TW, Feldman G, Popovich BW, Watson MS, Richards CS: Technical standards and guidelines: Venous thromboembolism (factor V Leiden and prothrombin 20210G>A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med, 7:444-453, 2005.